ARCHIVES

FDA Clears Avastin-Interferon Combination In Renal Cancer; Interferon Role Undefined.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

New Saccharin Studies Convince FDA It A Carcinogen

July 15, 1977

CCOP Review Committee Member Objects To “Unwarranted Criticism”

March 4, 1988

NCI, Advisors Concur On Need For New Mechanism To Include Cancer Control, Minority Center Needs

September 21, 1984

Benefit Seen In Novel Drug That Treats Gleevec Resistance

April 29, 2005

Funding Opportunities: ONS Invites Applications For Instrumentation Grants on Fatigue

January 24, 1997

NTP Committee Accepts Industry Positions On Policy To Separate Figures for Benign, Malignant Lesions

November 7, 1980